95.23 - 97.14
55.47 - 103.81
1.63M / 1.80M (Avg.)
55.57 | 1.74
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
-27.76%
Both firms have declining sales. Martin Whitman would suspect an industry slump or new disruptive entrants.
-37.06%
Both firms have negative gross profit growth. Martin Whitman would question the sector’s viability or cyclical slump.
-31.50%
Both companies show negative EBIT growth. Martin Whitman would consider macro or sector-specific headwinds.
-31.50%
Both companies face negative operating income growth. Martin Whitman would suspect broader market or cost hurdles.
31.79%
Positive net income growth while RGLD is negative. John Neff might see a big relative performance advantage.
30.30%
Positive EPS growth while RGLD is negative. John Neff might see a significant comparative advantage in per-share earnings dynamics.
30.30%
Positive diluted EPS growth while RGLD is negative. John Neff might view this as a strong relative advantage in controlling dilution.
0.05%
Share count expansion well above RGLD's 0.02%. Michael Burry would question if management is raising capital unnecessarily or is over-incentivizing employees with stock.
0.01%
Slight or no buyback while RGLD is reducing diluted shares. John Neff might consider the competitor’s approach more shareholder-friendly.
-52.12%
Dividend reduction while RGLD stands at 0.03%. Joel Greenblatt would question the firm’s cash flow stability or capital allocation decisions.
-25.13%
Both companies show negative OCF growth. Martin Whitman would analyze broader economic or industry conditions limiting cash flow.
-43.96%
Both companies show negative FCF growth. Martin Whitman would consider an industry-wide capital spending surge or margin compression.
6.31%
10Y revenue/share CAGR under 50% of RGLD's 52.98%. Michael Burry would suspect a lasting competitive disadvantage.
5.48%
5Y revenue/share CAGR under 50% of RGLD's 16.24%. Michael Burry would suspect a significant competitive gap or product weakness.
-3.20%
Negative 3Y CAGR while RGLD stands at 10.46%. Joel Greenblatt would look for missteps or fading competitiveness that hurt sales.
-5.92%
Negative 10Y OCF/share CAGR while RGLD stands at 60.79%. Joel Greenblatt would scrutinize managerial effectiveness and product competitiveness.
17.09%
5Y OCF/share CAGR at 50-75% of RGLD's 31.95%. Martin Whitman would question if the firm lags in monetizing revenue effectively.
7.38%
3Y OCF/share CAGR under 50% of RGLD's 33.11%. Michael Burry would worry about a significant short-term disadvantage in generating operational cash.
28.59%
Below 50% of RGLD's 67.54%. Michael Burry would worry about a sizable gap in long-term profitability gains vs. the competitor.
188.77%
5Y net income/share CAGR above 1.5x RGLD's 59.10%. David Dodd would confirm if the firm’s strategy is more effective in generating mid-term profits.
155.80%
Positive short-term CAGR while RGLD is negative. John Neff would see a clear advantage in near-term profit trajectory.
72.43%
10Y equity/share CAGR above 1.5x RGLD's 31.83%. David Dodd would confirm if consistent earnings retention or fewer write-downs drive this advantage.
26.47%
5Y equity/share CAGR 1.25-1.5x RGLD's 17.75%. Bruce Berkowitz confirms if reinvested profits or buybacks explain the superior buildup.
24.52%
3Y equity/share CAGR similar to RGLD's 23.40%. Walter Schloss sees both having parallel profitability or reinvestment over 3 years.
24.20%
Below 50% of RGLD's 132.78%. Michael Burry might see weaker long-term distribution growth, raising questions about the firm's capital allocation.
49.75%
Similar 5Y dividend/share CAGR to RGLD's 45.80%. Walter Schloss sees parallel philosophies in mid-term capital returns.
70.16%
3Y dividend/share CAGR above 1.5x RGLD's 32.07%. David Dodd sees a superior short-term capital return strategy if supported by stable earnings.
-31.31%
Both reduce receivables yoy. Martin Whitman suspects a shift in the entire niche’s credit approach or softer demand.
-5.56%
Inventory is declining while RGLD stands at 3.94%. Joel Greenblatt sees potential cost and margin benefits if sales hold up.
2.15%
Asset growth well under 50% of RGLD's 18.36%. Michael Burry sees the competitor as far more aggressive in building resources or capacity.
2.00%
BV/share growth above 1.5x RGLD's 0.85%. David Dodd confirms if consistent profit retention or fewer write-downs yield faster equity creation.
-11.95%
We’re deleveraging while RGLD stands at 0.00%. Joel Greenblatt considers if we gain a balance-sheet advantage for potential downturns.
No Data
No Data available this quarter, please select a different quarter.
-23.88%
Both reduce SG&A yoy. Martin Whitman sees a cost war or cyclical slowdown forcing overhead cuts.